Rethinking the Future of Science

Stefan Oschmann was Chairman of the Executive Board and CEO of Merck until 2021. He drove the transformation of the Biopharma business by optimizing its cost structures and improving the efficiency of its research & development model. Before joining Merck, Stefan Oschmann worked for the U.S. pharma company MSD, where he served in a range of senior executive positions.

Sara Weber is a German-American journalist and author. As Managing Editor DACH and Benelux at LinkedIn News, she leads the editorial teams in the German and Dutch-language regions. Sara graduated from Deutsche Journalistenschule (DJS) and previously worked as a freelance journalist.

Dr. Pardis Sabeti is a Professor of Immunology and Infectious Diseases at Harvard University. Her computational genomic lab has contributed to viral sequencing, information theory, rural disease surveillance and education efforts in West Africa. Sabeti is also a co-creator of the educational program Operation Outbreak.